1.A case of Beckwith-Wiedemann Syndrome.
Nam Joo HWANG ; Soo Mi BACK ; Yang Suk CHOI ; Son Sang SOE ; Hye Kyoung YOON
Journal of the Korean Pediatric Society 1990;33(3):373-379
No abstract available.
Beckwith-Wiedemann Syndrome*
2.A Case of Metatropic Dwarfism.
Eun Ok RHEE ; Nam Joo HWANG ; Yaung Sook CHOI ; Son Sang SEO ; Hye Kyoung YOON
Journal of the Korean Pediatric Society 1989;32(8):1167-1173
No abstract available.
Dwarfism*
3.Moderate to Severe Left Ventricular Ejection Fraction Related to Short-term Mortality of Patients with Post-cardiac Arrest Syndrome after Out-of-Hospital Cardiac Arrest.
Kyoung Jeen MIN ; Jin Joo KIM ; In Cheol HWANG ; Jae Hyuk WOO ; Yong Su LIM ; Hyuk Jun YANG ; Keun LEE
Korean Journal of Critical Care Medicine 2016;31(4):342-350
BACKGROUND: The aim of this study was to investigate the relationships between left ventricular ejection fraction (LVEF) and mortality and neurologic outcomes with post-cardiac arrest syndrome (PCAS) after out-of-hospital cardiac arrest (OHCA). METHODS: Patients with PCAS after OHCA admitted to the intensive care unit between January 2014 and December 2015 were analyzed retrospectively. RESULTS: total of 104 patients were enrolled in this study. The mean age was 54.4 ± 15.3 years, and 75 of the patients were male (72.1%). Arrest with a cardiac origin was found in 55 (52.9%). LVEF < 45%, 45-55%, and > 55% was measured in 39 (37.5%), 18 (17.3%), and 47 (45.2%) of patients, respectively. In multivariate analysis, severe LV dysfunction (LVEF < 45%) was significantly related to 7-day mortality (odds ratio 3.02, 95% Confidence Interval 1.01-9.0, p-value 0.047). CONCLUSIONS: In this study, moderate to severe LVEF within 48 hours after return of spontaneous circulation was significantly related to 7-day short-term mortality in patients with PCAS after OHCA. Clinicians should actively treat myocardial dysfunction, and further studies are needed.
Echocardiography
;
Humans
;
Intensive Care Units
;
Male
;
Mortality*
;
Multivariate Analysis
;
Out-of-Hospital Cardiac Arrest*
;
Passive Cutaneous Anaphylaxis
;
Retrospective Studies
;
Stroke Volume*
4.Nutmeg liver cardiac cirrhosis caused by constrictive pericarditis.
Kyoung Hwang SHIN ; Hyun Don JOO ; Il Han SONG
The Korean Journal of Internal Medicine 2015;30(6):938-939
No abstract available.
Aged
;
Biopsy
;
Humans
;
Liver Cirrhosis/diagnosis/*etiology/therapy
;
Male
;
Pericarditis, Constrictive/*complications/diagnosis/therapy
;
Tomography, X-Ray Computed
5.Erratum: Moderate to Severe Left Ventricular Ejection Fraction Related to Short-term Mortality of Patients with Post-cardiac Arrest Syndrome after Out-of-Hospital Cardiac Arrest.
Kyoung Jeen MIN ; Jin Joo KIM ; In Cheol HWANG ; Jae Hyuk WOO ; Yong Su LIM ; Hyuk Jun YANG ; Keun LEE
Korean Journal of Critical Care Medicine 2017;32(1):88-88
The author's affiliation should be corrected. We apologize for any inconvenience that may have caused.
6.A successful laparoscopic neovaginoplasty using peritoneum in Müllerian agenesis with inguinal ovaries accompanied by primary ovarian insufficiency.
Seonghye GWEON ; Jisun LEE ; Suna HWANG ; Kyoung Joo HWANG ; Miran KIM
Obstetrics & Gynecology Science 2016;59(4):342-345
The combination of Müllerian agenesis with inguinal ovaries accompanied by primary ovarian insufficiency is extremely rare. A 21-year-old Korean woman was referred to our center with primary amenorrhea. The patient was diagnosed with Müllerian agenesis with inguinal ovaries. Her hormonal profile showed hypergonadotrophic hypogonadism suggesting primary ovarian insufficiency. We performed laparoscopic neovaginoplasty using modified Davydov's procedure and reposition inguinal ovaries in the pelvic cavity. Oral estrogen replacement was applied for the treatment of primary ovarian insufficiency. This is a rare case report on Mayer-Rokitansky-Kuster-Hauser syndrome accompanied not only by inguinal ovaries but also with primary ovarian insufficiency. We present our first experience on the laparoscopic neovaginoplasty performed on the patient with müllerian agenesis accompanied by inguinal ovaries and primary ovarian insufficiency.
Amenorrhea
;
Estrogen Replacement Therapy
;
Female
;
Humans
;
Hypogonadism
;
Laparoscopy
;
Ovary*
;
Peritoneum*
;
Primary Ovarian Insufficiency*
;
Young Adult
7.Expression Pattern of Progesterone Receptor, Integrin, Cyclooxygenase (COX) in Human Endometrium of Patients with Endometriosis.
Mi Ran KIM ; Dong Wook PARK ; Kyoung Joo HWANG ; Kie Suk OH ; Hyck Chan KWON ; Hee Jae JOO ; Dong Jae CHO
Korean Journal of Fertility and Sterility 2000;27(2):117-132
OBJECTIVES: To develop a new immunohistochemical marker system for supplementation of the Noyes histological classification of the endometrium in women of child bearing age with regular menstrual cycles, and to employ this system to evaluate pathologic factors involved in endometriosis, and thus to ascertain if it is useful in diagnosis. MATERIALS AND METHODS: Endometrial biopsies were sampled from the posterior fundus of 41 (24 proliferative phases, 17 secretory phases) women with regular menstrual cycles (28-32 days), and each sample was immunhistochemically stained according to Noyes et al (1975) for determination of expression for extrogen receptor (ER), progesterone receter(PR), integrin alpha1, alpha4, beta3, COX-1 and COX-2. Then, the PR, the integrin beta3, and COX-2 which were clearly expressed in the luteal phase was with endometrial samples were obtained from 20 cases of normal patients (group 1) and 25 cases with endometriosis (group 2) after confirming the day of ovulation by sex steroid level measurements 7-8 days after ovulation. RESULTS: In the regular menstruation group the expression of ER showed a tendency to be increased in the proliferative phase and decreased in the secretory phase, and was the highest in the proliferative phase. However, PR in the stromal cells showed no change in the entire menstrual cycle while in the epithelial cells, PR reached a peak in the late proliferative phase and was almost absent in the secretory phase. Integrin alpha 1, alpha4, and beta3 expression in the epithelial cells was absent in the proliferative phase but alpha1 was expressed strongly in the early and mid secretory phases and disappeared in the late proliferative phase, while beta3, appeared after the mid secretory phase and continued to be expressed until the late secretory phase. Expression in the stromal cells was weak overall and did not show any cyclic pattern. COX-1 expression was shown as a cyclic pattern in the stromal and epithelial cells and was partcularly strongly expressed in the mid secretory phase of epithelial cells, and in the mid secretory and menstruation phase of stromal cells. In the endometrial epithelial cells there was strong expression during the entire cycle with stronger expression in the secretory phase compared to the prolferative phase. COX-2 was clearly expressed in the late proliferative, early and mid secretory phased in the stromal cells. No expression was observed in the proliferative phase of the epithelial cells, but which began to appear in the early secretory phase reaching a significant pattern from the mid secretory phase onwards. There was almost no expression in the stromal cells. In the cases with endometriosis showing normal endometrial maturation according to the Noyes classification, PR expression was increased while Integrin-beta3 expression was significantly decreased compared to the normal group. Also, COX-2 expression was slightly decreased in the stromal cells of patients with endometriosis while it was significantly increased in the stromal cells. CONCLUSION: Immunohistochemical markers can supplement the original Noyes classification of histological endometrial dating and therefore ascertain existing pathologic conditions. Particularly for patients with endometriosis with normally mature endometrial cells, changes in COX-2 and integrin expression patterns may assist in elucidating pathophysiologic mechanisms and therefore aid in the diagnosis of abnormal implantation conditions, and consequently determine a treatment modality.
Biopsy
;
Child
;
Classification
;
Diagnosis
;
Endometriosis*
;
Endometrium*
;
Epithelial Cells
;
Female
;
Humans*
;
Integrin alpha1
;
Integrin beta3
;
Luteal Phase
;
Menstrual Cycle
;
Menstruation
;
Ovulation
;
Progesterone*
;
Prostaglandin-Endoperoxide Synthases*
;
Receptors, Progesterone*
;
Stromal Cells
8.Expression pattern of progesterone receptor, integrinbeta(3), cyclooxygenase-2 ( COX-2 ) in human endometrium of patient with the disease related implantation.
June Seo LEE ; Dong Wook PARK ; Hyuck Chan KWON ; Mi Ran KIM ; Kyoung Joo HWANG ; Hee Jae JOO ; Dong Jae CHO ; Sei Kwang KIM ; Kie Suk OH
Korean Journal of Obstetrics and Gynecology 2000;43(6):961-967
OBJECTIVE: We compared the expression pattern of progesterone receptor, integrin 3, cyclooxygenase-2 (COX-2) in in-phased endomerium of patient with the disease related implantation and control group, and tried to confirm the clinical efficacy of the immunohistochemical markers for discrimination of occult uterine receptivity defect in in-phase endometrium. STUDY DESIGN: Endometrial tissues were obtained from 60 women with normal (group 1; n = 20), uterine synechiae (group 2; n = 15), and endometriosis (group 3; n = 25). On 7 ~ 8 days after ovulation (POD 7 ~ 8), sex hormone levels were measured and immunohistochemical staining of PR, integrin 3, and COX-2 expression were performed. RESULTS: PR was decreased in the group 2 and increased in the group 3 comparing with the group 1. integrin 3 expression was significantly decreased in the group 2 and 3. COX-2 expression was significantly decreased in the group 2. But, in the group 3, COX-2 expression was slightly increased in glandular epithelial cells, and significantly increased in stromal cells. CONCLUSIONS: In-phase biopsies from patients with endometriosis and uterine synechiae showed different expression pattern of integrin 3, COX-2, and PR compared to the control. The aberrant expression of immunohistochemical markers be associated with occult uterine receptivity defect and produce the useful diagnostic method.
Biopsy
;
Cyclooxygenase 2*
;
Discrimination (Psychology)
;
Endometriosis
;
Endometrium*
;
Epithelial Cells
;
Female
;
Gynatresia
;
Humans*
;
Ovulation
;
Progesterone*
;
Receptors, Progesterone*
;
Stromal Cells
9.Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus.
Ji Hee HWANG ; Ju Hyung LEE ; Jeong Hwan HWANG ; Kyung Min CHUNG ; Eun Jung LEE ; Yong Joo YOON ; Mi Kyoung MOON ; Ju Sin KIM ; Kyoung Suk WON ; Chang Seop LEE
Journal of Korean Medical Science 2015;30(6):688-693
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of ear infections. We attempted to evaluate the clinical usefulness of arbekacin in treating chronic suppurative otitis media (CSOM) by comparing its clinical efficacy and toxicity with those of vancomycin. Efficacy was classified according to bacterial elimination or bacteriologic failure and improved or failed clinical efficacy response. Ninety-five subjects were diagnosed with CSOM caused by MRSA. Twenty of these subjects were treated with arbekacin, and 36 with vancomycin. The bacteriological efficacy (bacterial elimination, arbekacin vs. vancomycin: 85.0% vs. 97.2%) and improved clinical efficacy (arbekacin vs. vancomycin; 90.0% vs. 97.2%) were not different between the two groups. However, the rate of complications was higher in the vancomycin group (33.3%) than in the arbekacin group (5.0%) (P=0.020). In addition, a total of 12 adverse reactions were observed in the vancomycin group; two for hepatotoxicity, one for nephrotoxicity, eight for leukopenia, two for skin rash, and one for drug fever. It is suggested that arbekacin be a good alternative drug to vancomycin in treatment of CSOM caused by MRSA.
Adult
;
Aged
;
Anti-Bacterial Agents/administration & dosage
;
Chronic Disease
;
Dibekacin/administration & dosage/*analogs & derivatives
;
Female
;
Humans
;
Male
;
Methicillin-Resistant Staphylococcus aureus/*drug effects
;
Middle Aged
;
Otitis Media, Suppurative/diagnosis/*drug therapy/microbiology
;
Staphylococcal Infections/diagnosis/*drug therapy/microbiology
;
Treatment Outcome
;
Vancomycin/*administration & dosage
;
Young Adult
10.High Incidence of Staphylococcus aureus and Norovirus Gastroenteritis in Infancy: A Single-Center, 1-Year Experience.
Kyoung SUNG ; Ji Yong KIM ; Yeoun Joo LEE ; Eun Ha HWANG ; Jae Hong PARK
Pediatric Gastroenterology, Hepatology & Nutrition 2014;17(3):140-146
PURPOSE: The etiology of acute gastroenteritis (AGE) has changed since the introduction of the rotavirus vaccination. The aim of this study was to clarify which common pathogens, both bacterial and viral, are currently causing AGE in infants. METHODS: Infants with acute diarrhea were enrolled. We tested for 10 bacterial pathogens and five viral pathogens in stool specimens collected from infants with AGE. The clinical symptoms such as vomiting, mucoid or bloody diarrhea, dehydration, irritability, and poor oral intake were recorded, and laboratory data such as white blood cell count and C-reactive protein were collected. The clinical and laboratory data for the cases with bacterial pathogens and the cases with viral pathogens were compared. RESULTS: Of 41 total infants, 21 (51.2%) were positive for at least one pathogen. Seventeen cases (41.5%) were positive for bacterial pathogens and seven cases (17.1%) were positive for viral pathogens. Staphylococcus aureus (13 cases, 31.7%) and Clostridium perfringens (four cases, 9.8%) were common bacterial pathogens. Norovirus (five cases, 12.2%) was the most common viral pathogen. Fever and respiratory symptoms were common in the isolated viral infection group (p=0.023 and 0.044, respectively), whereas other clinical and laboratory data were indistinguishable between the groups. CONCLUSION: In our study, S. aureus (41.5%) and norovirus (12.2%) were the most common bacterial and viral pathogens, respectively, among infants with AGE.
C-Reactive Protein
;
Clostridium perfringens
;
Dehydration
;
Diarrhea
;
Epidemiology
;
Fever
;
Gastroenteritis*
;
Humans
;
Incidence*
;
Infant
;
Korea
;
Leukocyte Count
;
Norovirus*
;
Rotavirus
;
Staphylococcus aureus*
;
Vaccination
;
Vomiting